|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 05018762.4 (espacenet) (Federated) (European Patent Register), 20000228 | | Patent/reg. no. and date | DK/EP 1609505, 20131211 | | Publication date | 20051228 | | Priority no. and date | US 259911, 19990301, US 259910, 19990301 | | EP pub. no. and date |
EP 1609505 20051228 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | NGC/AP/148120 | | Inventor | Schmutz, Markus, Baumgartenweg 24
4124 Schönenbuch, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4192 (2006.01) , A61P 25/00 (2006.01) | | Title | Anvendelse af fluorerede triazoler til behandling af affektive lidelser eller opmærksomhedsforstyrrelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
